Medexus Pharmaceuticals, Inc. (MDP.TO)
3.19
+0.04
(+1.27%)
CAD |
TSX |
Mar 04, 11:35
Medexus Pharmaceuticals Profit Margin (Quarterly) : 0.32% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cannara Biotech, Inc. (DELISTED) | 3.45% |
| NexgenRx, Inc. | 14.04% |
| Aurora Spine Corp. | -3.21% |
| Cronos Group, Inc. | -1.10% |
| NeuPath Health, Inc. | -0.43% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -0.59% |
| Return on Assets | -0.18% |
| Return on Invested Capital | -0.37% |
| Gross Profit Margin (Quarterly) | 53.34% |
| Operating Margin (Quarterly) | 6.61% |
| Return on Net Operating Assets | -0.22% |